David W. Osborne, Chief Technical Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,394 shares at $25.41 ($112K) on 2022-07-08, disclosed to the SEC on 2022-07-12.
Open-market sale of $112k ARQT by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.41 | 2,197 | $56K | 50.0% |
| 2 | $25.41 | 2,197 | $56K | 50.0% |
| Total | $25.41 avg | 4,394 | $112K | 100% |
| Filing → |
| ARQT | SELL | 2022-04-21 | $45K | — | Filing → |
| ARQT | SELL | 2022-03-07 | $14K | — | Filing → |
| ARQT | SELL | 2022-03-03 | $14K | — | Filing → |